Rebecca E. Watts
University of Queensland
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Rebecca E. Watts.
International Journal of Medical Microbiology | 2009
Amada N. Mabbett; Glen C. Ulett; Rebecca E. Watts; Jai J. Tree; Makrina Totsika; Cheryl-lynn Y. Ong; Jacqueline M. Wood; Wayne Monaghan; David Looke; Graeme R. Nimmo; Catharina Svanborg; Mark A. Schembri
In asymptomatic bacteriuria (ABU), bacteria colonize the urinary tract without provoking symptoms. Here, we compared the virulence properties of a collection of ABU Escherichia coli strains to cystitis and pyelonephritis strains. Specific urinary tract infection (UTI)-associated virulence genes, hemagglutination characteristics, siderophore production, hemolysis, biofilm formation, and the ability of strains to adhere to and induce cytokine responses in epithelial cells were analyzed. ABU strains were phylogenetically related to strains that cause symptomatic UTI. However, the virulence properties of the ABU strains were variable and dependent on a combination of genotypic and phenotypic factors. Most ABU strains adhered poorly to epithelial cells; however, we also identified a subgroup of strongly adherent strains that were unable to stimulate an epithelial cell IL-6 cytokine response. Poor immune activation may represent one mechanism whereby ABU E. coli evade immune detection after the establishment of bacteriuria.
Journal of Clinical Microbiology | 2010
Rebecca E. Watts; Viktoria Hancock; Cheryl-lynn Y. Ong; Rebecca Munk Vejborg; Amanda N. Mabbett; Makrina Totsika; David Looke; Graeme R. Nimmo; Per Klemm; Mark A. Schembri
ABSTRACT Urinary tract infections (UTIs) are among the most common infectious diseases of humans, with Escherichia coli being responsible for >80% of all cases. Asymptomatic bacteriuria (ABU) occurs when bacteria colonize the urinary tract without causing clinical symptoms and can affect both catheterized patients (catheter-associated ABU [CA-ABU]) and noncatheterized patients. Here, we compared the virulence properties of a collection of ABU and CA-ABU nosocomial E. coli isolates in terms of antibiotic resistance, phylogenetic grouping, specific UTI-associated virulence genes, hemagglutination characteristics, and biofilm formation. CA-ABU isolates were similar to ABU isolates with regard to the majority of these characteristics; exceptions were that CA-ABU isolates had a higher prevalence of the polysaccharide capsule marker genes kpsMT II and kpsMT K1, while more ABU strains were capable of mannose-resistant hemagglutination. To examine biofilm growth in detail, we performed a global gene expression analysis with two CA-ABU strains that formed a strong biofilm and that possessed a limited adhesin repertoire. The gene expression profile of the CA-ABU strains during biofilm growth showed considerable overlap with that previously described for the prototype ABU E. coli strain, 83972. This is the first global gene expression analysis of E. coli CA-ABU strains. Overall, our data suggest that nosocomial ABU and CA-ABU E. coli isolates possess similar virulence profiles.
Biochemical Journal | 2013
Maud E. S. Achard; Kaiwen W. Chen; Matthew J. Sweet; Rebecca E. Watts; Kate Schroder; Mark A. Schembri; Alastair G. McEwan
Iron acquisition is an important aspect of the host-pathogen interaction. In the case of Salmonella it is established that catecholate siderophores are important for full virulence. In view of their very high affinity for ferric iron, functional studies of siderophores have been almost exclusively focused on their role in acquisition of iron from the host. In the present study, we investigated whether the siderophores (enterobactin and salmochelin) produced by Salmonella enterica sv. Typhimurium could act as antioxidants and protect from the oxidative stress encountered after macrophage invasion. Our results show that the ability to produce siderophores enhanced the survival of Salmonella in the macrophage mainly at the early stages of infection, coincident with the oxidative burst. Using siderophore biosynthetic and siderophore receptor mutants we demonstrated that salmochelin and enterobactin protect S. Typhimurium against ROS (reactive oxygen species) in vitro and that siderophores must be intracellular to confer full protection. We also investigated whether other chemically distinct siderophores (yersiniabactin and aerobactin) or the monomeric catechol 2,3-dihydroxybenzoate could provide protection against oxidative stress and found that only catecholate siderophores have this property. Collectively, the results of the present study identify additional functions for siderophores during host-pathogen interactions.
Infection and Immunity | 2015
Scott A. Beatson; Nouri L. Ben Zakour; Makrina Totsika; Brian M. Forde; Rebecca E. Watts; Amanda N. Mabbett; Jan M. Szubert; Sohinee Sarkar; Minh-Duy Phan; Kate M. Peters; Nicola K. Petty; Nabil-Fareed Alikhan; Mitchell Sullivan; Jayde A. Gawthorne; Mitchell Stanton-Cook; Nguyen Thi Khanh Nhu; Teik Min Chong; Wai-Fong Yin; Kok-Gan Chan; Viktoria Hancock; David W. Ussery; Glen C. Ulett; Mark A. Schembri
ABSTRACT Urinary tract infections (UTIs) are among the most common infectious diseases of humans, with Escherichia coli responsible for >80% of all cases. One extreme of UTI is asymptomatic bacteriuria (ABU), which occurs as an asymptomatic carrier state that resembles commensalism. To understand the evolution and molecular mechanisms that underpin ABU, the genome of the ABU E. coli strain VR50 was sequenced. Analysis of the complete genome indicated that it most resembles E. coli K-12, with the addition of a 94-kb genomic island (GI-VR50-pheV), eight prophages, and multiple plasmids. GI-VR50-pheV has a mosaic structure and contains genes encoding a number of UTI-associated virulence factors, namely, Afa (afimbrial adhesin), two autotransporter proteins (Ag43 and Sat), and aerobactin. We demonstrated that the presence of this island in VR50 confers its ability to colonize the murine bladder, as a VR50 mutant with GI-VR50-pheV deleted was attenuated in a mouse model of UTI in vivo. We established that Afa is the island-encoded factor responsible for this phenotype using two independent deletion (Afa operon and AfaE adhesin) mutants. E. coli VR50afa and VR50afaE displayed significantly decreased ability to adhere to human bladder epithelial cells. In the mouse model of UTI, VR50afa and VR50afaE displayed reduced bladder colonization compared to wild-type VR50, similar to the colonization level of the GI-VR50-pheV mutant. Our study suggests that E. coli VR50 is a commensal-like strain that has acquired fitness factors that facilitate colonization of the human bladder.
The Journal of Infectious Diseases | 2012
Rebecca E. Watts; Chee K. Tan; Glen C. Ulett; Alison J. Carey; Makrina Totsika; Adi Idris; Adrienne W. Paton; Renato Morona; James C. Paton; Mark A. Schembri
Faculty of Health; Institute of Health and Biomedical Innovation | 2015
Scott A. Beatson; Nouri L. Ben Zakour; Makrina Totsika; Brian M. Forde; Rebecca E. Watts; Amanda N. Mabbett; Jan M. Szubert; Sohinee Sarkar; Minh-Duy Phan; Kate M. Peters; Nicola K. Petty; Nabil-Fareed Alikhan; Mitchell Sullivan; Jayde A. Gawthorne; Mitchell Stanton-Cook; Nguyen Thi Khanh Nhu; Teik Min Chong; Wai-Fong Yin; Kok-Gan Chan; Viktoria Hancock; David W. Ussery; Glen C. Ulett; Mark A. Schembri
Faculty of Health; Institute of Health and Biomedical Innovation | 2012
Rebecca E. Watts; Chee K. Tan; Glen C. Ulett; Alison J. Carey; Makrina Totsika; Adi Idris; Adrienne W. Paton; Renato Morona; James C. Paton; Mark A. Schembri
Faculty of Health; Institute of Health and Biomedical Innovation | 2012
Rebecca E. Watts; Makrina Totsika; Victoria L. Challinor; Amanda N. Mabbett; Glen C. Ulett; James J. De Voss; Mark A. Schembri
Faculty of Health; Institute of Health and Biomedical Innovation | 2010
Rebecca E. Watts; Viktoria Hancock; Cheryl-lynn Y. Ong; Rebecca Munk Vejborg; Amanda N. Mabbett; Makrina Totsika; David Looke; Graeme R. Nimmo; Per Klemm; Mark A. Schembri
Faculty of Health; Institute of Health and Biomedical Innovation | 2009
Amanda N. Mabbett; Glen C. Ulett; Rebecca E. Watts; Jai J. Tree; Makrina Totsika; Cheryl-lynn Y. Ong; Jacqueline M. Wood; Wayne Monaghan; David Looke; Graeme R. Nimmo; Catharina Svanborg; Mark A. Schembri